デフォルト表紙
市場調査レポート
商品コード
1770820

バイオマニュファクチャリング・ウイルス検出・定量市場- 世界の産業規模、動向、機会、予測、提供タイプ別、技術別、用途別、エンドユーザー別、地域別、競合別、2020-2030年

Biomanufacturing Viral Detection and Quantifications Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Offering Type, By Technology, By Application, By End-User, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 198 Pages
納期
2～3営業日
カスタマイズ可能
バイオマニュファクチャリング・ウイルス検出・定量市場- 世界の産業規模、動向、機会、予測、提供タイプ別、技術別、用途別、エンドユーザー別、地域別、競合別、2020-2030年
出版日: 2025年07月14日
発行: TechSci Research
ページ情報: 英文 198 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

バイオマニュファクチャリング・ウイルス検出・定量の世界市場は、2024年に4億9,346万米ドルと評価され、2030年には8億3,586万米ドルに達し、CAGR 9.14%で成長すると予測されています。

この市場は、臨床、環境、研究サンプル中のウイルス病原体を検出・定量するために使用される試薬、機器、診断システムの大規模生産を包含します。バイオテクノロジー、分子生物学、工学の原理を統合したバイオマニュファクチャリングは、PCR、ELISA、その他の分子診断のような技術に不可欠なツールの一貫したスケーラブルな開発を可能にします。これらの技術は、診断キットや、ポイント・オブ・ケアや実験室での使用が増加しているバイオセンサーやマイクロ流体工学を含むハイスループット・プラットフォームの作成をサポートします。この分野は、迅速なウイルスの検出と測定を可能にし、監視、診断、対応活動における世界の保健システムをサポートする上で重要な役割を担っています。主な分野には、分子診断学、免疫診断学、バイオセンサー技術、細胞ベースのアッセイなどがあり、これらすべてがウイルスの脅威をタイムリーに特定し管理することに貢献しています。

市場概要
予測期間 2026-2030
市場規模：2024年 4億9,346万米ドル
市場規模：2030年 8億3,586万米ドル
CAGR：2025年～2030年 9.14%
急成長セグメント ELISA
最大市場 アジア太平洋

市場促進要因

ウイルス性疾患の増加

主な市場課題

急速に進化するウイルス

主な市場動向

新興感染症への備え

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のバイオマニュファクチャリング・ウイルス検出・定量市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 提供タイプ別（消耗品、機器、サービス）
    • 技術別（PCR、ELISA、フローサイトメトリー、プラークアッセイ、その他）
    • 用途別（血液および血液製品の製造、ワクチンおよび治療薬の製造、細胞および遺伝子治療製品の製造、幹細胞製品の製造、組織および組織製品の製造）
    • エンドユーザー別（ライフサイエンス企業、試験機関、CRO、CDMO）
    • 企業別（2024）
    • 地域別
  • 市場マップ

第6章 北米のバイオマニュファクチャリング・ウイルス検出・定量市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州のバイオマニュファクチャリング・ウイルス検出・定量市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域のバイオマニュファクチャリング・ウイルス検出・定量市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米のバイオマニュファクチャリング・ウイルス検出・定量市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカのバイオマニュファクチャリング・ウイルス検出・定量市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 製品上市
  • 合併と買収

第13章 PESTEL分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Danaher Corporation
  • Merck KGaA
  • New England Biolabs
  • TAKARA HOLDINGS INC.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Sartorius AG
  • Charles River Laboratories
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc

第16章 戦略的提言

第17章 調査会社について・免責事項

目次
Product Code: 15881

The Global Biomanufacturing Viral Detection and Quantifications Market was valued at USD 493.46 million in 2024 and is projected to reach USD 835.86 million by 2030, growing at a CAGR of 9.14%. This market encompasses the large-scale production of reagents, instruments, and diagnostic systems used to detect and quantify viral agents in clinical, environmental, and research samples. Integrating biotechnological, molecular biology, and engineering principles, biomanufacturing enables the consistent and scalable development of tools essential for techniques like PCR, ELISA, and other molecular diagnostics. These technologies support the creation of diagnostic kits and high-throughput platforms, including biosensors and microfluidics, which are increasingly used in point-of-care and laboratory settings. The sector plays a critical role in enabling rapid virus detection and measurement, supporting global health systems in their surveillance, diagnosis, and response efforts. Key areas include molecular diagnostics, immunodiagnostics, biosensor technologies, and cell-based assays-all of which contribute to the timely identification and management of viral threats.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 493.46 Million
Market Size 2030USD 835.86 Million
CAGR 2025-20309.14%
Fastest Growing SegmentELISA
Largest MarketAsia Pacific

Key Market Drivers

Increasing Incidence of Viral Diseases

The growing prevalence of viral diseases is a primary driver accelerating the demand for advanced viral detection and quantification tools. As of 2024, the World Health Organization reported over 4.2 million dengue cases globally and more than 95,000 mpox (formerly monkeypox) cases since its outbreak in 2022. These figures reflect the increasing urgency for effective diagnostic tools to identify and contain viral infections early.

Biomanufactured products such as PCR kits, ELISA tests, and CRISPR-based diagnostics are vital for fast and accurate virus detection from clinical and environmental samples. These tools facilitate early diagnosis, rapid treatment initiation, and containment of infectious diseases. In settings where diseases like dengue are endemic, early quantification of viral load is essential to assess disease severity and determine appropriate clinical interventions. As new viral threats emerge, the need for deployable, high-performance diagnostic solutions continues to grow.

Key Market Challenges

Rapidly Evolving Viruses

One of the major challenges in the market is the ability of viruses to mutate rapidly, which can compromise the accuracy and reliability of diagnostic assays. Genetic mutations can affect the regions targeted by primers, probes, or antibodies, resulting in false negatives or decreased assay sensitivity.

To maintain diagnostic accuracy, biomanufacturers must continually update assay formulations to account for emerging variants. This requires ongoing investment in R&D and flexible production systems that can respond to evolving viral genomes. Ensuring optimal binding affinity and specificity under these conditions is complex and resource-intensive, posing a challenge to sustained product performance in the face of dynamic viral evolution.

Key Market Trends

Emerging Infectious Diseases Preparedness

Preparedness for emerging infectious diseases (EIDs) is shaping the future of the biomanufacturing viral detection and quantification market. This trend emphasizes the need for agile and responsive diagnostic capabilities that can be deployed during novel outbreaks.

Manufacturers are prioritizing the development of flexible diagnostic platforms that can quickly adapt to new pathogens. Scalable production and modular assay designs enable rapid shifts in manufacturing focus during global health emergencies. Fast-track regulatory approvals, collaborative efforts with public health agencies, and real-time surveillance capabilities are further reinforcing this trend.

Biomanufactured viral detection tools are not only crucial for diagnostics but also for tracking disease spread, evaluating vaccine effectiveness, and informing public health strategies during outbreaks. The growing emphasis on global health security is driving investment in platforms that support EID surveillance, detection, and response.

Key Market Players

  • Danaher Corporation
  • Merck KGaA
  • New England Biolabs
  • TAKARA HOLDINGS INC.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Sartorius AG
  • Charles River Laboratories
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc

Report Scope:

In this report, the Global Biomanufacturing Viral Detection and Quantifications Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biomanufacturing Viral Detection and Quantifications Market, By Offering Type:

  • Consumables
  • Instruments
  • Services

Biomanufacturing Viral Detection and Quantifications Market, By Technology:

  • PCR
  • ELISA
  • Flow Cytometry
  • Plaque Assay
  • Others

Biomanufacturing Viral Detection and Quantifications Market, By Application:

  • Blood and Blood Products Manufacturing
  • Vaccines and Therapeutics Manufacturing
  • Cellular and Gene Therapy Products Manufacturing
  • Stem Cell Products Manufacturing
  • Tissue and Tissue Products Manufacturing

Biomanufacturing Viral Detection and Quantifications Market, By End User:

  • Life Science Companies
  • Testing Laboratories
  • CROs and CDMOs

Biomanufacturing Viral Detection and Quantifications Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Asia-Pacific

  • China
  • India
  • South Korea
  • Australia
  • Japan

Europe

  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biomanufacturing Viral Detection and Quantifications Market.

Available Customizations:

Global Biomanufacturing Viral Detection and Quantifications Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biomanufacturing Viral Detection and Quantifications Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Offering Type (Consumables, Instruments, Services)
    • 5.2.2. By Technology (PCR, ELISA, FLOW Cytometry, Plaque Assay, Others)
    • 5.2.3. By Application (Blood and Blood Products Manufacturing, Vaccine and Therapeutics Manufacturing, Cellular and Gene Therapy Products Manufacturing, Stem Cell Products Manufacturing, Tissue and tissue Products Manufacturing)
    • 5.2.4. By End-User (Life Science Companies, testing Laboratories, CROs and CDMOs)
    • 5.2.5. By Company (2024)
    • 5.2.6. By Region
  • 5.3. Market Map

6. North America Biomanufacturing Viral Detection and Quantifications Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Offering Type
    • 6.2.2. By Technology
    • 6.2.3. By Application
    • 6.2.4. By End-User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Offering Type
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End-User
    • 6.3.2. Mexico Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Offering Type
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End-User
    • 6.3.3. Canada Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Offering Type
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End-User

7. Europe Biomanufacturing Viral Detection and Quantifications Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Offering Type
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Offering Type
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End-User
    • 7.3.2. Germany Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Offering Type
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End-User
    • 7.3.3. United Kingdom Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Offering Type
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End-User
    • 7.3.4. Italy Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Offering Type
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End-User
    • 7.3.5. Spain Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Offering Type
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End-User

8. Asia-Pacific Biomanufacturing Viral Detection and Quantifications Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Offering Type
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Offering Type
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End-User
    • 8.3.2. India Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Offering Type
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End-User
    • 8.3.3. South Korea Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Offering Type
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End-User
    • 8.3.4. Japan Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Offering Type
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End-User
    • 8.3.5. Australia Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Offering Type
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End-User

9. South America Biomanufacturing Viral Detection and Quantifications Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Offering Type
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Offering Type
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End-User
    • 9.3.2. Argentina Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Offering Type
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End-User
    • 9.3.3. Colombia Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Offering Type
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End-User

10. Middle East and Africa Biomanufacturing Viral Detection and Quantifications Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Offering Type
    • 10.2.2. By Technology
    • 10.2.3. By Application
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Offering Type
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End-User
    • 10.3.2. Saudi Arabia Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Offering Type
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End-User
    • 10.3.3. UAE Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Offering Type
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Danaher Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Merck KGaA
  • 15.3. New England Biolabs
  • 15.4. TAKARA HOLDINGS INC.
  • 15.5. Thermo Fisher Scientific Inc.
  • 15.6. Agilent Technologies, Inc.
  • 15.7. Sartorius AG
  • 15.8. Charles River Laboratories
  • 15.9. Bio-Rad Laboratories, Inc.
  • 15.10. PerkinElmer, Inc

16. Strategic Recommendations

17. About Us & Disclaimer